TNXP
Tonix Pharmaceuticals Holding Corp
Price:  
0.37 
USD
Volume:  
1,633,826.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TNXP Relative Valuation

-8629.3%
Upside

As of 2024-03-03, the Relative Valuation of Tonix Pharmaceuticals Holding Corp (TNXP) is (31.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.37 USD, the upside of Tonix Pharmaceuticals Holding Corp based on Relative Valuation is -8629.3%.

The range of the Relative Valuation is (27.71) - (35.88) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 18.5x - 25.3x 22.4x
Forward P/E multiples 17.5x - 24.0x 19.7x
Fair Price (27.71) - (35.88) (31.52)
Upside -7596.1% - -9808.4% -8629.3%
0.37 USD
Stock Price
(31.52) USD
Fair Price

TNXP Relative Valuation - Historical P/E Data

Date P/E
2024-03-01 -0.25
2024-02-29 -0.25
2024-02-28 -0.25
2024-02-27 -0.25
2024-02-26 -0.23
2024-02-23 -0.22
2024-02-22 -0.21
2024-02-21 -0.23
2024-02-20 -0.25
2024-02-16 -0.25
2024-02-15 -0.26
2024-02-14 -0.26
2024-02-13 -0.24
2024-02-12 -0.25
2024-02-09 -0.22
2024-02-08 -0.22
2024-02-07 -0.22
2024-02-06 -0.22
2024-02-05 -0.22
2024-02-02 -0.22
2024-02-01 -0.23
2024-01-31 -0.21
2024-01-30 -0.21
2024-01-29 -0.21
2024-01-26 -0.20
2024-01-25 -0.21
2024-01-24 -0.19
2024-01-23 -0.19
2024-01-22 -0.20
2024-01-19 -0.19
2024-01-18 -0.18
2024-01-17 -0.19
2024-01-16 -0.21
2024-01-12 -0.20
2024-01-11 -0.19
2024-01-10 -0.21
2024-01-09 -0.21
2024-01-08 -0.24
2024-01-05 -0.25
2024-01-04 -0.25
2024-01-03 -0.26
2024-01-02 -0.28
2023-12-29 -0.27
2023-12-28 -0.27
2023-12-27 -0.28
2023-12-26 -0.27
2023-12-22 -0.27
2023-12-21 -0.25
2023-12-20 -0.25
2023-12-19 -0.40